Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Simulation and resident education in spinal neurosurgery.

Surgical neurology international

Bohm PE, Arnold PM.
PMID: 25745588
Surg Neurol Int. 2015 Feb 26;6:33. doi: 10.4103/2152-7806.152146. eCollection 2015.

BACKGROUND: A host of factors have contributed to the increasing use of simulation in neurosurgical resident education. Although the number of simulation-related publications has increased exponentially over the past two decades, no studies have specifically examined the role of...

Cite
Bohm PE, Arnold PM. Simulation and resident education in spinal neurosurgery. Surg Neurol Int. 2015;6:33doi: 10.4103/2152-7806.152146.
Bohm, P. E., & Arnold, P. M. (2015). Simulation and resident education in spinal neurosurgery. Surgical neurology international, 633. https://doi.org/10.4103/2152-7806.152146
Bohm, Parker E, and Arnold, Paul M. "Simulation and resident education in spinal neurosurgery." Surgical neurology international vol. 6 (2015): 33. doi: https://doi.org/10.4103/2152-7806.152146
Bohm PE, Arnold PM. Simulation and resident education in spinal neurosurgery. Surg Neurol Int. 2015 Feb 26;6:33. doi: 10.4103/2152-7806.152146. eCollection 2015. PMID: 25745588; PMCID: PMC4348802.
Copy Download .nbib Format: NLM
Grade 1 spondylolisthesis and interspinous device placement: removal in six patients and analysis of current data.

Surgical neurology international

Bohm PE, Anderson KK, Friis EA, Arnold PM.
PMID: 25883846
Surg Neurol Int. 2015 Apr 02;6:54. doi: 10.4103/2152-7806.154461. eCollection 2015.

BACKGROUND: In the treatment of patients with Grade 1 spondylolisthesis, the use of interspinous devices has been controversial for nearly a decade. Several authors have suggested that Grade 1 spondylolisthesis be considered a contraindication for interspinous device placement.METHODS: We...

Cite
Bohm PE, Anderson KK, Friis EA, et al. Grade 1 spondylolisthesis and interspinous device placement: removal in six patients and analysis of current data. Surg Neurol Int. 2015;6:54doi: 10.4103/2152-7806.154461.
Bohm, P. E., Anderson, K. K., Friis, E. A., & Arnold, P. M. (2015). Grade 1 spondylolisthesis and interspinous device placement: removal in six patients and analysis of current data. Surgical neurology international, 654. https://doi.org/10.4103/2152-7806.154461
Bohm, Parker E, et al. "Grade 1 spondylolisthesis and interspinous device placement: removal in six patients and analysis of current data." Surgical neurology international vol. 6 (2015): 54. doi: https://doi.org/10.4103/2152-7806.154461
Bohm PE, Anderson KK, Friis EA, Arnold PM. Grade 1 spondylolisthesis and interspinous device placement: removal in six patients and analysis of current data. Surg Neurol Int. 2015 Apr 02;6:54. doi: 10.4103/2152-7806.154461. eCollection 2015. PMID: 25883846; PMCID: PMC4395982.
Copy Download .nbib Format: NLM
The era of integrative genomics: more data or better methods?.

Epigenomics

Koestler DC, Jones MJ, Jones M, Kobor MS, Kobor M.
PMID: 25431938
Epigenomics. 2014;6(5):463-7. doi: 10.2217/epi.14.44.

No abstract available.

Cite
Koestler DC, Jones MJ, Jones M, et al. The era of integrative genomics: more data or better methods?. Epigenomics. 2014;6(5):463-7doi: 10.2217/epi.14.44.
Koestler, D. C., Jones, M. J., Jones, M., Kobor, M. S., & Kobor, M. (2014). The era of integrative genomics: more data or better methods?. Epigenomics, 6(5), 463-7. https://doi.org/10.2217/epi.14.44
Koestler, Devin C, et al. "The era of integrative genomics: more data or better methods?." Epigenomics vol. 6,5 (2014): 463-7. doi: https://doi.org/10.2217/epi.14.44
Koestler DC, Jones MJ, Jones M, Kobor MS, Kobor M. The era of integrative genomics: more data or better methods?. Epigenomics. 2014;6(5):463-7. doi: 10.2217/epi.14.44. PMID: 25431938; PMCID: PMC4414242.
Copy Download .nbib Format: NLM
Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer.

Cancers

Peluso JJ, Pru JK.
PMID: 34885064
Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235953.

Cancers of the female reproductive tract are both lethal and highly prevalent. For example, the five-year survival rate of women diagnosed with ovarian cancer is still less than 50%, and endometrial cancer is the fourth most common cancer in...

Cite
Peluso JJ, Pru JK. Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235953.
Peluso, J. J., & Pru, J. K. (2021). Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer. Cancers, 13(23), . https://doi.org/10.3390/cancers13235953
Peluso, John J, and Pru, James K. "Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235953
Peluso JJ, Pru JK. Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer. Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235953. PMID: 34885064; PMCID: PMC8656518.
Copy Download .nbib Format: NLM
Clinical detection of deletion structural variants in whole-genome sequences.

NPJ genomic medicine

Noll AC, Miller NA, Smith LD, Yoo B, Fiedler S, Cooley LD, Willig LK, Petrikin JE, Cakici J, Lesko J, Newton A, Detherage K, Thiffault I, Saunders CJ, Farrow EG, Kingsmore SF.
PMID: 29263817
NPJ Genom Med. 2016 Aug 03;1:16026. doi: 10.1038/npjgenmed.2016.26. eCollection 2016.

Optimal management of acutely ill infants with monogenetic diseases requires rapid identification of causative haplotypes. Whole-genome sequencing (WGS) has been shown to identify pathogenic nucleotide variants in such infants. Deletion structural variants (DSVs, >50 nt) are implicated in many...

Cite
Noll AC, Miller NA, Smith LD, et al. Clinical detection of deletion structural variants in whole-genome sequences. NPJ Genom Med. 2016;1:16026doi: 10.1038/npjgenmed.2016.26.
Noll, A. C., Miller, N. A., Smith, L. D., Yoo, B., Fiedler, S., Cooley, L. D., Willig, L. K., Petrikin, J. E., Cakici, J., Lesko, J., Newton, A., Detherage, K., Thiffault, I., Saunders, C. J., Farrow, E. G., & Kingsmore, S. F. (2016). Clinical detection of deletion structural variants in whole-genome sequences. NPJ genomic medicine, 116026. https://doi.org/10.1038/npjgenmed.2016.26
Noll, Aaron C, et al. "Clinical detection of deletion structural variants in whole-genome sequences." NPJ genomic medicine vol. 1 (2016): 16026. doi: https://doi.org/10.1038/npjgenmed.2016.26
Noll AC, Miller NA, Smith LD, Yoo B, Fiedler S, Cooley LD, Willig LK, Petrikin JE, Cakici J, Lesko J, Newton A, Detherage K, Thiffault I, Saunders CJ, Farrow EG, Kingsmore SF. Clinical detection of deletion structural variants in whole-genome sequences. NPJ Genom Med. 2016 Aug 03;1:16026. doi: 10.1038/npjgenmed.2016.26. eCollection 2016. PMID: 29263817; PMCID: PMC5685307.
Copy Download .nbib Format: NLM
Neurochemical analysis of primary motor cortex in chronic low back pain.

Brain sciences

Sharma NK, Brooks WM, Popescu AE, Vandillen L, George SZ, McCarson KE, Gajewski BJ, Gorman P, Cirstea CM.
PMID: 23766894
Brain Sci. 2012 Sep 01;2(3):319-31. doi: 10.3390/brainsci2030319.

The involvement of the primary motor cortex (M1) in chronic low back pain (LBP) is a relatively new concept. Decreased M1 excitability and an analgesic effect after M1 stimulation have been recently reported. However, the neurochemical changes underlying these...

Cite
Sharma NK, Brooks WM, Popescu AE, et al. Neurochemical analysis of primary motor cortex in chronic low back pain. Brain Sci. 2012;2(3):319-31doi: 10.3390/brainsci2030319.
Sharma, N. K., Brooks, W. M., Popescu, A. E., Vandillen, L., George, S. Z., McCarson, K. E., Gajewski, B. J., Gorman, P., & Cirstea, C. M. (2012). Neurochemical analysis of primary motor cortex in chronic low back pain. Brain sciences, 2(3), 319-31. https://doi.org/10.3390/brainsci2030319
Sharma, Neena K, et al. "Neurochemical analysis of primary motor cortex in chronic low back pain." Brain sciences vol. 2,3 (2012): 319-31. doi: https://doi.org/10.3390/brainsci2030319
Sharma NK, Brooks WM, Popescu AE, Vandillen L, George SZ, McCarson KE, Gajewski BJ, Gorman P, Cirstea CM. Neurochemical analysis of primary motor cortex in chronic low back pain. Brain Sci. 2012 Sep 01;2(3):319-31. doi: 10.3390/brainsci2030319. PMID: 23766894; PMCID: PMC3678773.
Copy Download .nbib Format: NLM
WITHDRAWN: Impact of Initial Antibiotic Selection on Adverse Outcomes Among Patients With Severe Sepsis and Septic Shock.

Chest

Whiles B, Deis A, Miller P, Simpson S.
PMID: 27185753
Chest. 2016 Apr;149(4):A188. doi: 10.1016/j.chest.2016.02.194. Epub 2016 Apr 08.

The Publisher regrets that this article is an accidental duplication of an article that has already been published in Crit Care Med, 43 (2015) 263, http://dx.doi.org/10.1097/01.ccm.0000474875.35054.b3. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article...

Cite
Whiles B, Deis A, Miller P, et al. WITHDRAWN: Impact of Initial Antibiotic Selection on Adverse Outcomes Among Patients With Severe Sepsis and Septic Shock. Chest. 2016;149(4):A188doi: 10.1016/j.chest.2016.02.194.
Whiles, B., Deis, A., Miller, P., & Simpson, S. (2016). WITHDRAWN: Impact of Initial Antibiotic Selection on Adverse Outcomes Among Patients With Severe Sepsis and Septic Shock. Chest, 149(4), A188. https://doi.org/10.1016/j.chest.2016.02.194
Whiles, Bristol, et al. "WITHDRAWN: Impact of Initial Antibiotic Selection on Adverse Outcomes Among Patients With Severe Sepsis and Septic Shock." Chest vol. 149,4 (2016): A188. doi: https://doi.org/10.1016/j.chest.2016.02.194
Whiles B, Deis A, Miller P, Simpson S. WITHDRAWN: Impact of Initial Antibiotic Selection on Adverse Outcomes Among Patients With Severe Sepsis and Septic Shock. Chest. 2016 Apr;149(4):A188. doi: 10.1016/j.chest.2016.02.194. Epub 2016 Apr 08. PMID: 27185753.
Copy Download .nbib Format: NLM
The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail.

Youth & society

Upadhyayula S, Ramaswamy M, Chalise P, Daniels J, Freudenberg N.
PMID: 29176915
Youth Soc. 2017 Nov;49(8):1057-1076. doi: 10.1177/0044118X15576736. Epub 2015 Mar 24.

The goal of this study was to understand whether ethnic pride among young, incarcerated Black and Latino men was associated with successful community reentry. We interviewed 397 Black and Latino men 16 to 18 years old in a New...

Cite
Upadhyayula S, Ramaswamy M, Chalise P, et al. The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail. Youth Soc. 2015;49(8):1057-1076doi: 10.1177/0044118X15576736.
Upadhyayula, S., Ramaswamy, M., Chalise, P., Daniels, J., & Freudenberg, N. (2017). The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail. Youth & society, 49(8), 1057-1076. https://doi.org/10.1177/0044118X15576736
Upadhyayula, Satyasree, et al. "The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail." Youth & society vol. 49,8 (2017): 1057-1076. doi: https://doi.org/10.1177/0044118X15576736
Upadhyayula S, Ramaswamy M, Chalise P, Daniels J, Freudenberg N. The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail. Youth Soc. 2017 Nov;49(8):1057-1076. doi: 10.1177/0044118X15576736. Epub 2015 Mar 24. PMID: 29176915; PMCID: PMC5699229.
Copy Download .nbib Format: NLM
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection.

Infectious diseases and therapy

Britt NS, Steed ME, Potter EM, Clough LA.
PMID: 25466443
Infect Dis Ther. 2014 Dec;3(2):321-31. doi: 10.1007/s40121-014-0050-x. Epub 2014 Dec 03.

INTRODUCTION: Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. Metronidazole and vancomycin are the primary treatment options for CDI, but increasing rates of antimicrobial resistance and severe, refractory disease have prompted the need for alternative agents....

Cite
Britt NS, Steed ME, Potter EM, et al. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infect Dis Ther. 2014;3(2):321-31doi: 10.1007/s40121-014-0050-x.
Britt, N. S., Steed, M. E., Potter, E. M., & Clough, L. A. (2014). Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infectious diseases and therapy, 3(2), 321-31. https://doi.org/10.1007/s40121-014-0050-x
Britt, Nicholas S, et al. "Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection." Infectious diseases and therapy vol. 3,2 (2014): 321-31. doi: https://doi.org/10.1007/s40121-014-0050-x
Britt NS, Steed ME, Potter EM, Clough LA. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infect Dis Ther. 2014 Dec;3(2):321-31. doi: 10.1007/s40121-014-0050-x. Epub 2014 Dec 03. PMID: 25466443; PMCID: PMC4269622.
Copy Download .nbib Format: NLM
Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy.

Journal of diabetes & metabolism

Yoo M, Sharma N, Pasnoor M, Kluding PM.
PMID: 25360348
J Diabetes Metab. 2013 Jun 30; doi: 10.4172/2155-6156.S10-005.

Diabetic peripheral neuropathy (DPN) is a frequent complication of diabetes and a major cause of morbidity and increased mortality. It is typically characterized by significant deficits in tactile sensitivity, vibration sense, lower-limb proprioception, and kinesthesia. Painful diabetic neuropathy (P-DPN)...

Cite
Yoo M, Sharma N, Pasnoor M, et al. Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy. J Diabetes Metab. 2013;doi: 10.4172/2155-6156.S10-005.
Yoo, M., Sharma, N., Pasnoor, M., & Kluding, P. M. (2013). Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy. Journal of diabetes & metabolism, . https://doi.org/10.4172/2155-6156.S10-005
Yoo, Min, et al. "Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy." Journal of diabetes & metabolism vol. (2013). doi: https://doi.org/10.4172/2155-6156.S10-005
Yoo M, Sharma N, Pasnoor M, Kluding PM. Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy. J Diabetes Metab. 2013 Jun 30; doi: 10.4172/2155-6156.S10-005. PMID: 25360348; PMCID: PMC4211105.
Copy Download .nbib Format: NLM
Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Journal of neuromuscular diseases

Statland J, Donlin-Smith CM, Tapscott SJ, van der Maarel S, Tawil R.
PMID: 25705588
J Neuromuscul Dis. 2014;1(2):181-190. doi: 10.3233/JND-140034.

BACKGROUND: Recent studies have proposed a unified genetic model for Facioscapulohumeral muscular dystrophy (FSHD), identifying potential therapeutic targets for future clinical trials. Serum biomarkers related to disease activity will be important for proof of concept or early phase clinical...

Cite
Statland J, Donlin-Smith CM, Tapscott SJ, et al. Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy. J Neuromuscul Dis. 2014;1(2):181-190doi: 10.3233/JND-140034.
Statland, J., Donlin-Smith, C. M., Tapscott, S. J., van der Maarel, S., & Tawil, R. (2014). Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy. Journal of neuromuscular diseases, 1(2), 181-190. https://doi.org/10.3233/JND-140034
Statland, Jeffrey, et al. "Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy." Journal of neuromuscular diseases vol. 1,2 (2014): 181-190. doi: https://doi.org/10.3233/JND-140034
Statland J, Donlin-Smith CM, Tapscott SJ, van der Maarel S, Tawil R. Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy. J Neuromuscul Dis. 2014;1(2):181-190. doi: 10.3233/JND-140034. PMID: 25705588; PMCID: PMC4332410.
Copy Download .nbib Format: NLM
Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies.

Journal of neuromuscular diseases

Statland JM, Odrzywolski KJ, Shah B, Henderson D, Fricke AF, van der Maarel SM, Tapscott SJ, Tawil R.
PMID: 26345300
J Neuromuscul Dis. 2015;2(3):291-299. doi: 10.3233/JND-150077.

BACKGROUND: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis.OBJECTIVE: To determine the histopathological changes in FSHD muscle biopsies and compare to...

Cite
Statland JM, Odrzywolski KJ, Shah B, et al. Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies. J Neuromuscul Dis. 2015;2(3):291-299doi: 10.3233/JND-150077.
Statland, J. M., Odrzywolski, K. J., Shah, B., Henderson, D., Fricke, A. F., van der Maarel, S. M., Tapscott, S. J., & Tawil, R. (2015). Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies. Journal of neuromuscular diseases, 2(3), 291-299. https://doi.org/10.3233/JND-150077
Statland, Jeffrey M, et al. "Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies." Journal of neuromuscular diseases vol. 2,3 (2015): 291-299. doi: https://doi.org/10.3233/JND-150077
Statland JM, Odrzywolski KJ, Shah B, Henderson D, Fricke AF, van der Maarel SM, Tapscott SJ, Tawil R. Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies. J Neuromuscul Dis. 2015;2(3):291-299. doi: 10.3233/JND-150077. PMID: 26345300; PMCID: PMC4560242.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries